SOURCE: Dutch Gold Resources

September 09, 2014 09:39 ET

Dutch Gold Reports Progress on Medical Cannabis Manual, Includes Recent Research on PTSD and MMJ

ATLANTA, GA--(Marketwired - Sep 9, 2014) - Dutch Gold Resources, Inc. (PINKSHEETS: DGRI) (the "Company") ( today announced that it has completed the initial drafting of the first section of the Medical Cannabis Manual, and that the company will provide access to all of the most recent MMJ research as it becomes available. Further the Company reports that it will deploy the scientific data that it has assembled to create new products for MMJ patients.

Recently the University of Haifa reported that MMJ may have both therapeutic and prophylactic use of patients who have been exposed to trauma. The report may be accessed in full by clicking on

"The science behind the Medical Cannibis Manual is ultimately what will drive value to patients and clinicians," said Daniel Hollis, CEO. "As a company we are committed to serving the needs of patients and providers. With the information that we are assembling, we, as a company are becoming much more discerning about the business initiatives that we wish to fund. The use of MMJ as a potential therapeutic agent for the prevention and treatment PTSD is significant. We intend to use the information that we are publishing to tailor-make products using CBD's for patients who suffer." 

The Medical Cannabis Manual is a 500 page comprehensive medical text for health care practitioners. Designed for clinical application, the Medical Cannabis Manual provides information for therapeutic use for substantiated and recognized disease entities and disorders, including recommended use guidelines, descriptions of medical cannabis strains, contraindications and adverse reactions, use with prescription and over the counter medications, and employment with alternative and complementary medicine. The Medical Cannabis Manual contains 10 quick-reference monochromatic charts and extensive research references for comprehension of the physiological basis for use of cannabinoids, making it ideal for both clinical and educational reference.

Forward-Looking Statements

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by Dutch Gold Resources, Inc. are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.

Contact Information

  • For further information, please see or please contact
    Daniel Hollis
    Dutch Gold Resources, Inc.